While global healthcare venture capital funding exhibits nominal top-line resilience, with total capital deployed projected to reach $81.3 Billion, representing a 16% annualised increase over the previous year, this aggregate liquidity masks a severe imbalance in capital allocation across different corporate maturity stages.